Biography of Dov Goldstein
Last update: March 2, 2024Career
Dov was Chief Financial Officer and Chief Business Offer at Indapta Therapeutics, and Director at NeuBase Therapeutics.
Dov Goldstein is currently- Chief Financial Officer at BioAge - View - BioAge org chart
- Chairman of the Board at NeuBase Therapeutics - View - NeuBase Therapeutics org chart
- Director at Coya Therapeutics - View - Coya Therapeutics org chart
- Independent Member at Gain Therapeutics - View - Gain Therapeutics org chart
Create your alert
to follow the career of Dov Goldstein.
Education
Dov Goldstein has a Doctor of Medicine from Yale University - School of Medicine in 1995 and a Master of Business Administration in Finance from Columbia University - Business School in 1998.
They have also studied at Yale University - School of Medicine :
- Yael Margolin - Scinai Immunotherapeutics
- Vishal Agrawal - Humana
- Laurie Smaldone Alsup - BlackBerry
Find more alumni from Yale University - School of Medicine
They have also studied at Columbia University - Business School :
Find more alumni from Columbia University - Business School
More about Dov Goldstein
Selected links
Do you need to know more about Dov Goldstein? More results.
Participate
Social media
- Dov Goldstein on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Dov Goldstein
The colleagues of Dov Goldstein
Company Colleagues
- At BioAge, Dov Goldstein has 18 colleagues including Kristen Fortney (CEO & Director), Vijay Pande (Director)…
- At NeuBase Therapeutics, Dov Goldstein has 4 colleagues including Dietrich Stephan (CEO), Gerald McDougall (Director)…
- At Coya Therapeutics, Dov Goldstein has 12 colleagues including Howard Berman (CEO & Chairman), Wilbur Ross (Director)…
- At Gain Therapeutics, Dov Goldstein has 15 colleagues including Matthias Alder (CEO & Director), Jeffrey Riley (Director)…
Industry Colleagues
- In the Biotechnology industry, Dov Goldstein has 30,266 colleagues in 2,283 companies located in 40 countries. 14,430 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Dov Goldstein.
Get in Touch
and ask for Dov Goldstein.
